InvestorsHub Logo

megazoo

03/24/23 9:10 PM

#19773 RE: Drugdoctor #19771

That is true for every piblic company. People resign and people get appointed.

The only big deal is that the new guy is a private equity veteran. Is there a chance that he will help Dye take SHWZ public?

GoldRu$$H

03/24/23 9:26 PM

#19775 RE: Drugdoctor #19771

Of course, you already know this........right Doc?

https://ir.schwazze.com/static-files/ae7701ab-1002-43f7-8d80-bb9185491cd1

Mr. Stewart was designated for appointment to the Board as the joint designee of Brian Ruden and Naser Joudeh pursuant to the Omnibus Amendment No.
2 to Asset Purchase Agreements, dated December 17, 2020, among the Company and the sellers party thereto (the “Omnibus Amendment”). Between
December 17, 2020 and March 2, 2021, the Company’s wholly-owned subsidiary, SBUD LLC, acquired the assets of a number of Star Buds retail
dispensaries located in Colorado. The Omnibus Amendment provides that, for as long as the Sellers (as defined in the Omnibus Amendment) and the
Members (as defined in the Omnibus Amendment) meet a specified ownership threshold, the Company shall recommend to the Board that Brian Ruden
and Naser Joudeh jointly be permitted to designate three directors for appointment to the Board if the Board consists of seven or more members. Currently,
Pratap Mukharji, Marc Rubin, and Brad Stewart serve as Messrs. Ruden and Joudeh’s designees on the Board. The Company previously reported the terms
of the Omnibus Amendment in the Company’s Current Report on Form 8-K filed on December 23, 2020 and attached a copy of the Omnibus Amendment
as Exhibit 2.1 thereto, and such disclosure and exhibit are incorporated by reference herein.

Pratap Mukharji, Marc Rubin still serve as directors on the board.

https://www.marketscreener.com/quote/stock/MEDICINE-MAN-TECHNOLOGIES-120795967/news/Medicine-Man-Technologies-Inc-Announces-Executive-Changes-42214254/

Currently, Pratap Mukharji, Marc Rubin, and Salim Wahdan serve as Messrs. Ruden and Joudeh's designees on the Board. The Company previously reported the terms of the Omnibus Amendment in the Company's Current Report on Form 8-K filed on December 23, 2020 and attached a copy of the Omnibus Amendment as Exhibit 2.1 thereto, and such disclosure and exhibit are incorporated by reference herein.

In Plain Sight

03/25/23 12:14 AM

#19777 RE: Drugdoctor #19771

Highly qualified replacement Starbuds rep on the board. In and of itself...is that significant? M&A expertise? Hmm. Why did Sal agree to an early term? Why? I'm trying to put a puzzle together...I think some of the common ends are looking like Dominoe ends and as such my solution for point is near.

It gets a bit tiresome reading you pretending to be a rube, Doc. Apparently, we all get that. I'm guessing they tell us before April Fools what the import is. And something else. Perhaps, I only found the tip of a broken spear and as such am waiting patiently as well a like rube for no good reason. Nah.

Cannabis stocks. Self-effacing humor included with every share purchase almost guaranteed.